Chuang YC, Weng SF, Hsu YW, Huang CL, Wu MP. Increased risks of
healthcare-seeking behaviors of anxiety, depression and insomnia among patients
with bladder pain syndrome/interstitial cystitis: a nationwide population-based study. Int Urol Nephrol. 2015;47:275-81.
Hung-Jen Wang, Pradeep Tyagi , Yao-Chi Chuang*, Naoki Yoshimura , Chao-Cheng Huang, Michael B. Chancellor. Functional and Molecular Characteristics of Underactive Bladder Induced by Lumbar Canal Stenosis in Rats.
Urology. 2015;85:1284-90.
Liu YY, Chiang PH, Chuang YC, Lee WC, Cheng YT, Wang HJ. Predictors of prostate-specific antigen biochemical recurrence in patients undergoing primary whole-gland prostate cryoablation. Ann Surg Oncol. 2015 May;22(5):1612-7. doi: 10.1245/s10434-014-3942-9. Epub 2014 Oct 7.
Chuang YC, Plata M, Lamb LE, Chancellor MB. Underactive bladder in old adults. Clin Geriatr Med. 2015; 31:523-33 (SCI; IF=1.826).
Chuang YC*, Huang TL, Tyagi P, Huang CC. Urodynamic and Immunohistochemical Evaluation of Intravesical Botulinum Toxin A Delivery Using Low Energy Shock Wave. J Urol. 2016, 196; 599-608.
Lee WC, Wu CC, Chuang YC, Tain YL, Chiang PH. Ba-Wei-Die-Huang-Wan (Hachimi-jio-gan) Can Ameliorate Cyclophosphamide-induced Ongoing Bladder Overactivity and Acidic Adenosine Triphosphate Solution-induced Hyperactivity on Rats Prestimulated Bladder. J Ethnopharmacol. 2015 Dec 21. pii: S0378-8741(15)30277-4. doi: 10.1016/j.jep.2015.12.026. [Epub ahead of print]
Chuang YC, Chermansky C, Kashyap M, Tyagi P.. Investigational drugs for bladder pain syndrome (BPS) / interstitial cystitis (IC). Expert Opinion On Investigational Drugs. 2016,;25:521-9.
Shen YC, and Chuang YC*. The prevalence and predictors of androgen deficiency in Taiwanese men with lower urinary tract symptoms. Urolgical science. 2016, 27: 83-85
Hsu YC, Wang HJ, and Chuang YC *. Intraprostatic botulinum neurotoxin type A injection for benign prostatic hyperplasia- a spotlight loss in reality. Toxin?2016, 26;8(5). pii: E126. Review.�
Li CE, Chien CS, Chuang YC, Chang YI, Tang HP, Kang CH. Chronic kidneydisease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer. Int Urol Nephrol. 2016, 48:993-9.
Liu HY, Chung MS, Wang HJ, Liu RT*, Chuang YC*. Nocturia indicates a poorhealth status and increases mortality in male patients with type 2 diabetes mellitus. Int Urol Nephrol. 2016, 48: 1209-1214
Vikas Tyagi, Xianggui Qu, Yao-Chi Chuang, Hann-Chorng Kuo, Michael B. Chancellor . Elevated CXC Chemokines in Urine Non-invasively Discriminate OAB from UTI. Am J Physiol Renal Physiol. 2016 Sep 1;311(3):F548-54.
Shen YC, Chiang PH, Luo HL, Chuang YC, Chen YT, Kang CH, Hsu CC, Lee WC, Cheng YT. Determine of the optimal number of cycles of docetaxel in the treatment of metastatic castration-resistant prostate cancer. Kaohsiung J Med Sci. 2016 Sep;32(9):458-63.
Hung-Jen Wang, Wei-Chia Lee, Pradeep Tyagi , Chao-Cheng Huang, Yao-Chi Chuang*, Effects of Low Energy Shock Wave Therapy on Inflammatory Moleculars, Bladder Pain, and Bladder function in a Rat Cystitis Model. Neurourol Urodyn. 2017 Aug;36(6):1440-1447.
Chapple C, Castro-Diaz D, Chuang YC, Lee KS, Liao L, Liu SP, Wang J, Yoo TK, Chu R, Sumarsono B. Prevalence of Lower Urinary Tract Symptoms in China, Taiwan and South Korea: Results from a Cross-sectional, Population-based Study. Adv Ther. 2017 Aug;34(8):1953-1965.
Chuang YC, Liu SP, Lee KS, Liao L, Wang J, Yoo TK, Chu R, Sumarsono B.Prevalence of Overactive Bladder in China, Taiwan and South Korea: Results from a Cross-Sectional, Population-Based Study. LUTS, 2017 Oct 2. doi: 10.1111/luts.12193. [Epub ahead of print]
Chuang YC, Tyagi P, Wang HJ, Huang CC, Lin CC, Chancellor MB.Urodynamic and Molecular Characteristics of Detrusor Underactivity in a Rat Cryoinjury Model and Effects of Low Energy Shock Wave Therapy. Neurourol Urodyn. 2017 Aug 2. doi: 10.1002/nau.23381. [Epub ahead of print]
Wang HJ, Cheng JH, Chuang YC. Potential applications of low-energy shock waves in functional urology. Int J Urol. 2017 Aug;24(8):573-581.
Chuang YC, Kuo HC. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome. J Urol. 2017 Feb 12. pii: S0022-5347(17)30228-8. doi: 10.1016/j.juro.2017.02.021. [Epub ahead of print]
Lee KS, Yoo TK, Liao L, Wang J, Chuang YC, Liu SP, Chu R, Sumarsono B. Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study. BMC Urol. 2017 Nov 21;17(1):108. doi: 10.1186/s12894-017-0294-3.
Chuang YC, Liu SP, Lee KS, Liao L, Wang J, Yoo TK, Chu R, Sumarsono B. Prevalence of overactive bladder in China, Taiwan and South Korea: Results from a cross-sectional, population-based study. Low Urin Tract Symptoms. 2017 Oct 2. doi: 10.1111/luts.12193. [Epub ahead of print]
